STERIS plc (STE)

In the past six months, STERIS Plc stock experienced several notable events. In Q3 Fiscal Year 2026, STERIS announced strong financial results, with total revenue increasing 9% to $1.5 billion. An ex-dividend reminder was issued for STERIS. As of March 6, 2026, the stock was down 2.2% since its last earnings report and crossed below its 200-day moving average. STERIS's stock reached a 52-week high of $269.44 on January 16, 2026. The closing price as of April 7, 2026, was $219.22.

Demand for STERIS's products and services is primarily driven by consistent, long-term trends rather than distinct seasonal fluctuations. Key drivers include the increasing global aging population, a growing demand for medical procedures, and customers' desire for greater operational efficiency. The nature of healthcare and life sciences suggests a generally stable demand for the company's offerings.

STERIS Plc is an American-Irish medical equipment company specializing in infection prevention and procedural products and services. The company is legally registered in Dublin, Ireland, for tax purposes, with its operational headquarters in Mentor, Ohio, U.S. STERIS operates within the medical devices sector and aims to help customers create a healthier and safer world through innovative healthcare and life science solutions. Its offerings include infection control solutions, procedural products and services, applied sterilization technologies, and life sciences products. STERIS also provides equipment installation and maintenance, microbial reduction of medical devices, laboratory testing services, linen management, and off-site reprocessing.

While legally domiciled in Ireland, STERIS's primary operational presence is in the United States, accounting for 73.4% of its net sales. Ireland contributes 2% to net sales, with other international regions making up the remaining 24.6%. The company maintains a global footprint with key locations including manufacturing facilities and offices in the U.S., the UK, France, Finland, Canada, Mexico, Brazil, and Singapore.

STERIS has maintained a strong brand reputation, emphasizing its commitment to its mission of helping customers create a healthier and safer world through infection prevention. The company highlights its dedication to sustainability, which is integrated into its operations through efforts to minimize environmental impact, foster a diverse and inclusive workforce, and engage ethically with communities. Fourteen STERIS facilities in the United States have achieved OSHA's Star Level via the Voluntary Protection Program (VPP). STERIS also prioritizes corporate governance, cybersecurity, and compliance.

The majority of STERIS Plc's shares are held by institutional investors, accounting for 92.88% of shares, while individual investors held 4.88%, and insiders held 0.24%. Major institutional shareholders include Vanguard Group Inc., BlackRock Inc., Massachusetts Financial Services Co., and WCM Investment Management LLC.